Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Normal hair thickness varies by scalp area and a mix of hair thicknesses is typical in healthy individuals.

UK postgraduate health students have limited understanding of alopecia, with many misconceptions, highlighting the need for better awareness.

Combining genetic and physical data improves diagnosis and treatment for early-onset monogenic diabetes.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

A man's health improved after treating his undiagnosed adrenal insufficiency, which caused fatigue and weight loss.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Plasma protein binding significantly affects glucocorticosteroid concentration in blood, saliva, and hair.

The symposium concluded that environmental factors significantly contribute to skin aging.

Beauty is subjective and culturally variable, but certain facial features like symmetry are universally recognized as attractive.

Androgens can cause acne, excess hair, and hair loss, treatable with dermatologist-guided therapies.

Postmenopausal women often experience hair loss on the scalp and increased facial hair, but iron supplements may not help.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Hair properties change under electromagnetic fields and are influenced by individual characteristics and the environment.

The document lists dermatology topics across life stages and notes hair loss can affect self-esteem and early skin cancer treatment is crucial.

Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

Comma hairs are a specific sign of tinea capitis when viewed with videodermatoscopy.

PRP treatment helps hair growth and density in androgenetic alopecia patients.